Prices delayed by at least 15 minutes | Print
Global X Etfs Icav GLOBAL X GENOMICS & BIOTECHNOLOGY
Open
$11.00
Previous close
$10.958
Trade high
$11.014
Income frequency
-
Year low
$7.35
Year high
$13.214
Replication method
Physical Full
Volume
98,790
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.5
ISIN
IE00BM8R0N95
Share price
Asset allocation
Top 10 holdings
| Holdings 13/11/2026 | % of assets |
|---|---|
| Moderna Inc | 12.44 |
| 10x Genomics Inc Ordinary Shares - Class A | 5.34 |
| Twist Bioscience Corp | 5.31 |
| Guardant Health Inc | 5.24 |
| Illumina Inc | 4.90 |
| Natera Inc | 4.74 |
| Qiagen NV | 3.86 |
| Bio-Techne Corp | 3.84 |
| Vertex Pharmaceuticals Inc | 3.83 |
| Genscript Biotech Corp Class H | 3.56 |
Investment objective
The investment objective of the Fund is to provide investment results that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the “Index”).
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.